Early Fostamatinib Use Shows High Response Rates in Immune Thrombocytopenia
A nationwide Spanish real-world study of 72 adults with immune thrombocytopenia found that fostamatinib, an oral spleen tyrosine kinase inhibitor, ...
A nationwide Spanish real-world study of 72 adults with immune thrombocytopenia found that fostamatinib, an oral spleen tyrosine kinase inhibitor, ...
A multicenter Chinese real-world study found that the antibody-drug conjugate regimen Pola-R-CHP achieved a 92.6 percent complete response rate in ...
A five-gene plasma cfDNA methylation assay detected colorectal cancer with substantially higher sensitivity than CEA in a real-world cohort of ...
A real-world study of 526 patients found that paclitaxel liposome combined with anti-HER-2 targeted therapies delivered median overall survival of ...
A real-world study of 55 patients with advanced ROS1-rearranged non-small cell lung cancer shows that fusion subtype, PD-L1 expression and ...
A real-world study of 87 patients suggests that combining Trop-2 antibody-drug conjugates with PD-1 inhibitors and anti-angiogenic therapy substantially improves ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine